These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7850459)

  • 1. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal.
    Kreeger JS; Yukhananov RYu ; Larson AA
    Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine modulates excitatory amino acid-induced activity in the mouse spinal cord: short-term effects on N-methyl-D-aspartate (NMDA) and long-term effects on kainic acid.
    Yukhananov RYu ; Larson AA
    Brain Res; 1994 May; 646(2):194-200. PubMed ID: 8069663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine is mediated by sigma activity.
    Kreeger JS; Yukhananov RYu ; Larson AA
    Brain Res; 1995 Feb; 672(1-2):83-8. PubMed ID: 7749756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX.
    Goettl VM; Larson AA
    Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
    Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
    Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate.
    Sun X; Larson AA
    Neuroscience; 1993 Jun; 54(3):773-9. PubMed ID: 8101361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of NMDA receptors in naloxone-induced contractions of the isolated guinea pig ileum after preincubation with morphine.
    Yukhananov RYu ; Larson AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1365-70. PubMed ID: 7996448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
    Leal MB; Michelin K; Souza DO; Elisabetsky E
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
    Larson AA; Sun X
    Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
    Bespalov AY; Medvedev IO; Sukhotina IA; Zvartau EE
    Behav Pharmacol; 2001 Apr; 12(2):135-42. PubMed ID: 11396518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
    Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
    J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
    Dunbar S; Yaksh TL
    Anesthesiology; 1996 May; 84(5):1177-88. PubMed ID: 8624012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors.
    Watanabe C; Orito T; Watanabe H; Mizoguchi H; Yonezawa A; Yanai K; Mobarakeh JI; Onodera K; Sakurada T; Sakurada S
    Eur J Pharmacol; 2008 Feb; 581(1-2):54-63. PubMed ID: 18155693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
    Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
    Johnston IN; Westbrook RF
    Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.